The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties
The intestinal microbiota of patients with constipated-predominant irritable bowel syndrome (C-IBS) displays chronic dysbiosis. Our aim was to determine whether this microbial imbalance instigates perturbation of the host intestinal mucosal immune response, using a model of human microbiota-associat...
Main Authors: | Gobert, Alain P., Sagrestani, Giulia, Delmas, Eve, Wilson, Keith T., Verriere, Thomas G., Dapoigny, Michel, Del’homme, Christophe, Bernalier-Donadille, Annick |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159846/ |
Similar Items
-
Constipation-Predominant Irritable Bowel Syndrome Associated to Hyperprolactinemia
by: Seretis, C., et al.
Published: (2011) -
Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation
by: Eswaran, Shanti, et al.
Published: (2014) -
Autonomic nervous system activity in constipation-predominant irritable bowel syndrome patients
by: Mazur, Marcel, et al.
Published: (2012) -
Functional Constipation and Constipation-Predominant Irritable Bowel Syndrome in the General Population: Data from the GECCO Study
by: Enck, Paul, et al.
Published: (2016) -
Optimal management of constipation associated with irritable bowel syndrome
by: Furnari, Manuele, et al.
Published: (2015)